925 followers
New article: Apatinib in Patients with Relapsed or Refractory Diffuse Large B Cell Lymphoma: A Phase II, Open-Label, Single-Arm, Prospective Study. https://t.co/zuYAavzcBL #DLBCL #lymsm #hematology
New article: Apatinib in Patients with Relapsed or Refractory Diffuse Large B Cell Lymphoma: A Phase II, Open-Label, Single-Arm, Prospective Study. https://t.co/zuYAavzcBL #DLBCL #lymsm #hematology
Apatinib in Patients with Relapsed or Refractory Diffuse Large B Cell Lymphoma: A Phase II, Open-Label, Single-Arm, Prospective Study. #lymphoma #lymsm https://t.co/RUDxl3rziR